Notice: We are currently performing maintenance to improve the italaw platform. The site remains fully accessible. Thank you for your patience.

Eli Lilly and Company v. The Government of Canada, Notice of Intent to Submit a Claim to Arbitration Under NAFTA Chapter Eleven (Strattera and Zyprexa)

13 Jun 2013
Eli Lilly and Company v. The Government of Canada, UNCITRAL, ICSID Case No. UNCT/14/2
Document provided by: ICSID
View case details
Notice of Intent to Submit a Claim to Arbitration Under NAFTA Chapter Eleven (Strattera and Zyprexa)
Document Details:
LISTED PARTICIPANTS
Notice of Intent to Submit a Claim to Arbitration Under NAFTA Chapter Eleven (Strattera and Zyprexa)
Participants listed are for this document only and may not include all participants involved in the entire case. Always consult the original documents.
Claimant appointee
Respondent appointee
Tribunal/Panel chair
Arbitrator(s)
Sole Arbitrator
ICSID Annulment Committee president
ICSID Annulment Committee members
WTO Appellate Body members
WTO Appellate Body chair
Judges
Claimant's counsel
Claimant's law firm
Respondent's counsel
Respondent's law firm
Other counsel
Claimant's expert
Claimant's expert firm
Respondent's expert
Respondent's expert firm
Claimant's witness
Respondent's witness
Other witnesses
Tribunal secretary
Tribunal assistant
Third-party funder
Entities
Country
Print reporter
Document Summary
Notice of Intent to Submit a Claim to Arbitration Under NAFTA Chapter Eleven (Strattera and Zyprexa)
This summary note is machine-generated. Always consult the original materials.